Curanex Pharmaceuticals, Inc. (CURX)
4.410
-0.03
(-0.67%)
USD |
NASDAQ |
Nov 20, 16:00
4.44
+0.03
(+0.67%)
After-Hours: 20:00
Curanex Pharmaceuticals Enterprise Value : 5.879M for Nov. 20, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 5.879M |
| November 19, 2026 | 5.925M |
| November 18, 2026 | 6.333M |
| November 17, 2026 | 6.333M |
| November 16, 2026 | 6.231M |
| November 13, 2026 | 6.490M |
| November 12, 2026 | 7.854M |
| November 11, 2026 | 7.838M |
| November 10, 2026 | 8.513M |
| November 09, 2026 | 8.685M |
| November 06, 2026 | 8.701M |
| November 05, 2026 | 8.027M |
| November 04, 2026 | 8.058M |
| November 03, 2026 | 8.670M |
| November 02, 2026 | 8.136M |
| October 30, 2026 | 7.054M |
| October 29, 2026 | 6.709M |
| October 28, 2026 | 6.725M |
| October 27, 2026 | 6.435M |
| October 26, 2026 | 6.176M |
| October 23, 2026 | 6.239M |
| October 22, 2026 | 7.117M |
| October 21, 2026 | 6.819M |
| October 20, 2026 | 6.435M |
| October 19, 2026 | 6.678M |
| Date | Value |
|---|---|
| October 16, 2026 | 6.208M |
| October 15, 2026 | 6.537M |
| October 14, 2026 | 6.741M |
| October 13, 2026 | 6.615M |
| October 12, 2026 | 6.615M |
| October 09, 2026 | 7.290M |
| October 08, 2026 | 6.427M |
| October 07, 2026 | 6.443M |
| October 06, 2026 | 6.788M |
| October 05, 2026 | 6.741M |
| October 02, 2026 | 6.364M |
| October 01, 2026 | 6.756M |
| September 30, 2026 | 6.850M |
| September 29, 2026 | 4.386M |
| September 28, 2026 | 4.478M |
| September 25, 2026 | 4.060M |
| September 24, 2026 | 3.649M |
| September 23, 2026 | 3.684M |
| September 22, 2026 | 3.833M |
| September 21, 2026 | 3.536M |
| September 18, 2026 | 3.578M |
| September 17, 2026 | 3.862M |
| September 16, 2026 | 3.280M |
| September 15, 2026 | 3.422M |
| September 14, 2026 | 3.706M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Breakthrough Chemistry, Inc. | 0.8565M |
| Kaya Holdings, Inc. | -- |
| Cardiac Biotech Solutions, Inc. | 6.415M |
| Endexx Corp. | -- |
| Earth Science Tech, Inc. | 23.03M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.816M |
| Total Expenses (Quarterly) | 2.816M |
| EPS Diluted (Quarterly) | -1.857 |
| Earnings Yield | -194.3% |
| Normalized Earnings Yield | -194.29 |